Arkolith/Insider Trading/CLVS/Form 4

Harding Thomas C.

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Jun 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2022Sell(S)218$0.64$1403K
Jun 2, 2022Sell(S)2K$0.64$96315K
Jun 1, 2022Option exercise(M)507——3K
Jun 1, 2022Option exercise(M)3K——16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2022Option exercise(M)507—$04K
Jun 1, 2022Option exercise(M)3K—$032K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-020948) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML